Erythropoietin as a Neuroprotective Drug for Newborn Infants: Ten Years after the First Use

Protective strategies against perinatal brain injury represent a major challenge for modern neonatology. Erythropoietin (Epo) enhances endogenous mechanisms of repair and angiogenesis. In order to analyse the newest evidence on the role of Epo in prematurity, hypoxic ischemic encephalopathy (HIE) an...

Full description

Bibliographic Details

Published in:	Antioxidants
Main Authors:	Serafina Perrone, Chiara Lembo, Federica Gironi, Chiara Petrolini, Tiziana Catalucci, Giulia Corbo, Giuseppe Buonocore, Eloisa Gitto, Susanna Maria Roberta Esposito
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Subjects:	erythropoietin newborn neuroprotection preterm Hypoxic Ischemic Encephalopathy perinatal stroke
Online Access:	https://www.mdpi.com/2076-3921/11/4/652